| 摘要 |
[Objectives] To explore the therapeutic effect of Polygonum capitatum on renal calculus in rats based on network pharmacology. [Methods] Through the preliminary construction of P. capitatum-urolithiasis disease target network, explore the active components, action pathway and action target of P. capitatum-urolithiasis treatment, and use 1% ethylene glycol+2% ammonium chloride to induce SD rat kidney calcium oxalate stone model to verify the efficacy of P. capitatum-urolithiasis treatment. [Results] Through the network pharmacological prediction, it is found that the important active components in P. capitatum were quercetin, gallic acid, rutin, silybin, catechin, kaempferol and so on; potential active targets include INS, CAT, IL-6, MOCOS, etc. The results also suggest that forkhead transcription factor signaling pathway (FoxO signaling pathway), tumor necrosis factor signaling pathway (TNF signaling pathway) and hypoxia-inducible factor signaling pathway (HIF-1 signaling pathway) are the core pathways. The results of biochemical indicators in animal experiment showed that the contents of serum urea nitrogen (BUN), creatinine (Cr) and malondialdehyde (MDA) in renal tissue in the treatment group (200, 500 mg/kg) were significantly lower than those in the model group, while the content of superoxide dismutase (SOD) was significantly higher than that in the model group. In addition, the kidney tissue H&E staining sections showed that P. capitatum alcohol extract administration group rats kidney calcium oxalate crystals were significantly reduced compared with the model group, the degree of renal tubular lumen expansion was lighter than the model group, suggesting that P. capitatum alcohol extract has the effect of improving renal calculus in rats. [Conclusions] This study provides a theoretical reference for the deep development of P. capitatum in the treatment of renal calculus. |
